S100A8 and S100A9 levels are markedly increased in a wide range of inflammatory conditions, including autoimmune diseases, cancers, and neurodegenerative disorders, and they may serve as effective biomarkers for disease detection and prognosis (116). This evidence concerns the gene S100A9 and cancer.